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Abstract
Interferons (IFNs) are key regulators for both innate and adaptive immune responses. By screening
ENU-mutagenized mice, we identified a pedigree- P117 which displayed impaired response to type
I, but not type II, IFNs. Through inheritance test, genetic mapping and sequencing, we found a T to
A point mutation in the 5' splice site of STAT2 intron 4–5, leading to cryptic splicing and frame
shifting. As a result, the expression of STAT2 protein was greatly diminished in the mutant mice.
Nonetheless, a trace amount of functional STAT2 protein was still detectable and was capable of
inducing, though to a lesser extent, IFN-downstream gene expressions, suggesting that P117 is a
STAT2 hypomorphic mutant. The restoration of mouse or human STAT2 gene in P117 MEFs
rescued the response to IFN, suggesting that the mutation in STAT2 is most likely the cause of
the phenotypes seen in the pedigree. Development of different subsets of lymphocytes appeared
to be normal in the mutant mice except that the percentage and basal expression of CD86 in
splenic pDC and cDC were reduced. In addition, in vitro Flt3L-dependent DC development and TLR
ligand-mediated DC differentiation were also defective in mutant cells. These results suggest that
STAT2 positively regulates DC development and differentiation. Interestingly, a severe impairment
of antiviral state and increased susceptibility to EMCV infection were observed in the mutant MEFs
and mice, respectively, suggesting that the remaining STAT2 is not sufficient to confer antiviral
response. In sum, the new allele of STAT2 mutant reported here reveals a role of STAT2 for DC
development and a threshold requirement for full functions of type I IFNs.
Background
Interferon (IFN)s are classified into type I, II and III
according to the receptors they bind to. Type I IFNs family
consists of about 20 members of IFN and only one
member of IFN. The prominent function of type I IFNs is
interfering viral infections through blocking viral tran-
scription, degrading viral RNA, inhibiting translation and
modifying proteins to control viral replication [1]. Other
than antiviral responses, type I IFNs also exert different
functions, including modulating innate and adaptive
immunity, controlling cross presentation, promoting or
impeding differentiation of certain cell types, and inhibit-
ing cell proliferation [2,3]. Type II IFN consists of only
one species of IFN- IFN that is mainly produced by T and
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NK cells when stimulated and is critical to their effector
functions [4]. Other than regulating innate and adaptive
immune response, type I and II IFNs also play important
roles in cancer immunosurveillance and immunoediting,
which place IFNs in a critical position in anticancer ther-
apy [5].
Signal transduction of IFNs is mainly mediated by JAK-
STAT pathway [6]. The binding of IFN/ to IFNAR1 and
IFNAR2 leads to activation of JAK1 and TYK2 followed by
activation of STAT1, STAT2 and STAT3. STAT1, STAT2 and
IRF9 form hetero-trimer, bind to interferon stimulated
responsible element (ISRE) and transactivate downstream
genes. STAT1 and STAT3 can also form homo- or hetero-
dimers and bind to gamma activated site (GAS) to induce
a different set of genes. Likewise, when IFN binds to
IFNGR1 and IFNGR2, JAK1 and JAK2 are activated, which
in turn activate STAT1. Activated STAT1 forms dimers and
translocates into nucleus where the dimmer binds to GAS
element in the promoter region of IFNg-inducible genes
and trigger transactivation. The in vivo roles of STAT1,
STAT2, and STAT3 have been well established by gene tar-
geting in mice. Mice lacking STAT1 display severe impair-
ment of antiviral responses [7,8]. Likewise, mice lacking
STAT2 also exhibit similar phenotypes seen in STAT1KO
mice [9], implying a pivotal role of STAT1 and/or STAT2
in response to viral infection. Other than impaired antivi-
ral response, the functions of several immune cells includ-
ing NK and B cells are also affected in mice lacking STAT1
[10,11]. Conventional knockout of STAT3 leads to early
embryonic lethality, implying that STAT3 is developmen-
tally indispensible [12]. However, using Cre-loxP system
to induce STAT3 deletion in different tissues or organs
unveils multiple functions of STAT3, ranging from cell
survival, apoptosis, migration, development and differen-
tiation [13-16].
In this study, we identified and characterized a pedigree of
mutant mice (P117) which displayed impaired response
to type I, but not type II, IFNs. A T to A point mutation in
the 5' splice site of STAT2 intron 4–5 resulted in cryptic
splicing and frame shift, leading to diminished produc-
tion of STAT2 protein. Nonetheless, a small amount of
STAT2 was detectable and remained functional, suggest-
ing the STAT2 mutation results in hypomorphic and not
null phenotype. In vitro and in vivo assays showed that DC
development was defective in P117. Moreover, MEFs
derived from P117 mice and the mice were extremely sus-
ceptible to viral infections, suggesting that the remaining
STAT2 was not sufficient to confer antiviral response.
Results
Pedigree 117 displays impaired IFN response
Forward genetics or phenotype-driven approach using N-
ethyl-N-nitrosourea (ENU) to induce mutations in mice
provides a unique opportunity to assign functions to
genes in an unbiased manner [17,18]. To screen ENU-
mutagenized mice with defective IFN signaling, we
designed a two-step screening method. The first step was
to stimulate PBLs from ENU-mutagenized mice with IFN
or IFN, followed by measuring the surface expression of
MHC class I and ICAM-1, molecules downstream of IFNs,
by flow cytometry. Once deviant mice with enhanced or
reduced IFN response were identified, a second confirma-
tion step was performed. The PBLs of the deviant mice
were stimulated with IFNs and the expressions of IP-10,
OAS, PKR and SOCS1, four IFN-inducible genes were
quantified by RT-QPCR. After screening some 2800 G3
mice from 134 pedigrees, we identified P117 as a poor
IFN responder to be of great interest. As shown in Fig.
1A, PBLs from P117 stimulated by IFN expressed low
levels of MHC class I and ICAM-1 as compared with wild-
type controls. Likewise, the expressions of IFN-inducible
IP-10, OAS and PKR were also greatly reduced (Fig. 1B).
However, IFN-induced IP-10 and SOCS-1 expressions
were not affected in P117 mice (Fig. 1B). These results sug-
gest that ENU-induced mutation in P117 is specific to
IFN signaling pathway.
The mutation introduced to P117 is recessive and linked to 
Chromosome 10
To study if the reduced IFN response in P117 was inher-
itable, P117 was first crossed with one of its siblings. Inter-
estingly, a number of P117 offspring showed
hyporesponsiveness to IFN (Fig. 2A) which suggests the
phenotype is inheritable. We next determined if the phe-
notype was recessive or dominant. P117 (in C57BL/6
background) was first crossed to wild type C57BL/6 mice.
No aberrant response was observed in F1 mice. However,
the phenotype reappeared in the F1-intercrossed F2 mice,
suggesting that the aberrant IFN response was recessive.
To further confirm this finding, we crossed F1 mice with
wild-type C57BL/6 mice and the phenotype disappeared
in F2 mice. Together, the results of the inheritance test
suggest that the altered IFN response was recessive.
To identify that the mutation accounts for the aberrant
response to IFN, we first performed genetic mapping
using interval haplotype analysis [19]. First, G3 affected
male mouse was mated with C3H/HeJ females to generate
F1 offspring that were then intercrossed to generate F2
mice. Of 292 F2 mice, 70 (~24%) were affected. DNA
samples obtained from 15 individual affected F2 mice
were subjected to interval haplotype analysis. The results
are shown in Fig. 2B. Based on the percentage of maxi-
mum possible Chi square (%max 2) value, linkage of the
mutant gene was assigned to chromosome 10.Journal of Biomedical Science 2009, 16:22 http://www.jbiomedsci.com/content/16/1/22
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P117 displayed impaired IFN response Figure 1
P117 displayed impaired IFN response. (A) PBLs of ENU-mutagenized mice were stimulated without or with IFN 1000 
U/ml for 21 h followed by staining with antibodies to MHC class I and ICAM-1 and analyzed by flow cytometry. (B) PBLs of 
ENU-mutagenized mice were stimulated with IFN 500 ng/ml or IFN 1000 U/ml for 3 h followed by preparation of mRNA for 
RT-QPCR using primers to IP-10 (IFN and IFN), SOCS1 (IFN), OAS (IFN) and PKR (IFN). Stimulation index was calcu-
lated as described in the Materials and Methods. Relative mRNA was shown by normalizing the values of specific genes to that 
of -actin. Arrow heads are P117.
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Mutation in P117 was recessive and linked to chromosome 10 Figure 2
Mutation in P117 was recessive and linked to chromosome 10. (A) When P117 crossed with one of its siblings, a 
number of P117 offspring showed impaired IFN response. When P117 crossed with wild-type mice, none of the F1 mice 
showed the phenotype. When the F1 mice intercrossed, the phenotype reappeared in the F2 mice. However, the phenotype 
was not observed in F2 mice of F1 crossed with wild-type mice. Empty squares and circles are unaffected males and females, 
respectively. Solid squares and circles are affected males and females, respectively. (B) Haplotype analysis was done as 
described in the Materials and Methods. The physical linkage of the mutation to chromosome in the mutant mice was based on 
the percentage of the maximum possible 2 (%max 2). Solid bar: linked loci. Empty bars: unlinked loci.
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AT2 protein expression is diminished in P117
Since P117 selectively displayed reduced response to IFN
but not IFN, we reasoned that the affected molecule
might be one of the signal mediators specific to IFN such
as IFNAR1, IFNAR2, Tyk2, or STAT2. We first examined
the expression of STATs and phospho-STATs in cells after
stimulation with IFNs. Western blot analysis showed that
while the protein levels of STAT1 and STAT3 were compa-
rable in wild-type and P117 splenocytes, the STAT2 pro-
tein was not detectable in the mutant mice (Fig. 3A).
Likewise, the levels of STAT1 and STAT3 tyrosine phos-
phorylation in P117 mice were also comparable with
wild-type mice; yet IFN-induced pSTAT2 (Tyr689) was
completely undetectable in mutant cells. Immunohisto-
chemical staining also showed that although STAT2 pro-
tein was expressed in different organs, including liver,
kidney and the lung of wild-type mice, its expression in
p117 was greatly reduced (data not shown).
A T to A point mutation in 5' splice site of the STAT2 intron 4–5 resulted in diminished expression of STAT2 protein in P117 Figure 3
A T to A point mutation in 5' splice site of the STAT2 intron 4–5 resulted in diminished expression of STAT2 
protein in P117. (A) Splenocytes of wild-type or P117 mice were stimulated with IFN or IFN for 0, 3 and 6 h followed by 
Western blotting using antibodies to pSTAT1, STAT1, pSTAT2, STAT2, pSTAT3, STAT3 and -actin. (B) Genomic sequencing 
results of wild-type (left panels) or P117 (middle panels). cDNA sequencing of p117 (right panels) indicated the addition of 5 
nucleotides between exon 4 and exon 5. Schematic diagram of the mutation in the mouse STAT2 protein was shown (lower 
panel). PI: protein interaction, DBD: DNA binding domain, SH2: src homology 2, TAD: transactivation domain (C) Splenocytes 
of wild-type (empty bars), STAT2+/m (gray bars) and STAT2m/m (P117) (solid bars) mice were stimulated with IFN (250 U/ml) 
for 0, 3 and 6 h, followed by RT-QPCR for OAS gene expression. Inset: response in STAT2m/m (P117) cells in a smaller scale. 
Western blotting was done using antibody to STAT2. Arrow head indicated full length STAT2. Relative mRNA was shown by 
normalizing the values of OAS to that of -actin.
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To further examine whether the mutation was indeed har-
bored in the STAT2 gene, the STAT2 genomic DNA and
cDNA were sequenced. We identified a T to A point muta-
tion in the 5' splice site of intron 4–5 of the STAT2 gene in
P117 (Fig. 3B left and middle panels). The point mutation
was present in all the P117  that displayed altered IFN
response (data not shown). Mouse STAT2 gene encodes
923 amino acids in which 5 functional domains are
defined, namely protein interaction (PI), coiled-coil, DNA
binding (DBD), Src homology 2 (SH2), and transactiva-
tion domains (TAD) [20]. The mutation was located in
the coiled-coil domain of STAT2 close to its N-terminal
region (Fig. 3B lower panel). The point mutation resulted
in cryptic splicing of STAT2 mRNA by using a new 5' splice
site GU located three nucleotides downstream of the
mutation (Fig. 3B, right panel). The alternative splicing
caused frame-shift and created stop codons which left out
critical domains of STAT2 protein including DBD, SH2
and TAD. To further confirm the phenotype seen in P117,
we used RT-QPCR to examine induction of OAS gene by
IFN in splenocytes of wild-type, STAT2+/m and STAT2m/m
(P117) mice. As shown in Fig. 3C, OAS mRNA expression
was dramatically reduced in the mutant cells as opposed
to STAT2+/m or wild type control. Interestingly, however,
we also noted that OAS gene expression in P117 cells was
not completely diminished. Although the expression level
following IFN treatment for 6 h was approximately 1/40
of that in wild-type cells, it was still 20-fold higher than
basal level of OAS in P117. These results suggest that a
marginal IFN response was still at work in P117 cells. In
fact, at longer exposure, we observed a trace amount of
full-length STAT2 protein in the mutant cells whose
expression would increase further with time following
IFN treatment (Fig. 3C, inset). Therefore, we concluded
that P117 mice were STAT2 hypomorphic instead of null
mutant.
Restoration of STAT2 rescues IFN response in P117 MEFs
To confirm that IFN hyporesponsiveness in P117 was
due to mutation in STAT2 instead of elsewhere, we
restored wild-type STAT2 back to P117 MEFs. It is
reported that human and mouse STAT2 are divergent due
to the presence of repetitive sequence in the C-terminus of
the mouse STAT2 gene [20,21]. Therefore, bicistronic ret-
roviruses carrying either wild-type human or mouse
STAT2 gene and GFP were used to infect P117 MEFs. Judg-
ing from the percentage of GFP positive cells, the infection
efficiency was between 46% and 61% (Fig. 4A). The
infected cells were stimulated with IFN followed by RT-
QPCR to detect the induction of OAS and PKR mRNA. As
shown in Fig. 4B and 4C, OAS and PKR were readily
induced in control wild-type MEF after treatment. While
transduction with vector alone did not alter IFN hypore-
sponsiveness in the P117 MEF, restoration with hSTAT2
or mSTAT2 gene greatly rescued the inducibility of OAS
and PKR by IFN. These gain-of-function results suggest
that the aberrant IFN response in the mutant mice was
due to defect in STAT2 expression.
P117 displays impaired DC development in vivo and in 
vitro
To study whether STAT2 regulates hematopoiesis, cells
from bone marrow, thymus, PBL and spleen of wild-type
and P117 mice were stained and subjected to flow cytom-
etry. The percentage and numbers of T cell subsets in the
thymus, B cell subsets in the bone marrow and mature
CD4, CD8, and B cells in the PBL and spleen in P117 mice
were comparable to that in wild-type mice, suggesting that
STAT2 does not regulate the development of T or B cells
(data not shown). Since type I IFNs were reported to affect
the maturation and functions of DC [22,23], we further
tested if there was a defect in DC development in P117. As
shown in Fig. 5A and 5B, left panels, the percentages of
pDC (CD11c+B220+) and cDC (CD11c+CD11b+) were
greatly reduced in the spleen of STAT2m/m  (P117) as
opposed to STAT2+/m mice and the difference was statisti-
cally significant (Fig. 5C). The cellularity of both types of
DC was also reduced in the mutant (data not shown).
Likewise, the expression of CD86 on STAT2m/m (P117)
pDC or cDC was also decreased (Fig. 5A and 5B, right pan-
els).
It is reported that Flt3 signaling is important in DC devel-
opment [24-26]. We first studied in vitro Flt3L-dependent
DC development from BM. As shown in Fig. 5D and 5E,
the numbers of pDC and cDC and the percentage of pDC
from STAT2m/m (P117) were lower than that from STAT2+/
m mice after Flt3L stimulation although the percentage of
cDC from STAT2m/m (P117) mice was not different from
that of STAT2+/m  mice. Moreover, TLR ligand-induced
MHC class II was lower in STAT2m/m (P117) pDC than in
STAT2+/m pDC, although the basal level of MHC class II
expression was comparable in STAT2m/m  (P117) and
STAT2+/m pDC (Fig. 5F). The effect of TLR ligands on MHC
class II expression was even more pronounced in STAT2m/
m (P117) cDC. While the basal level of MHC class II
expression was lower in STAT2m/m (P117) cDC, its induc-
ibility by TLR ligands was almost impaired (Fig. 5G).
Experiments also show that the expression patterns of
CD86 and ICAM-1 on STAT2m/m (P117) pDC and cDC
were similar to that of MHC class II before and after TLR-
ligand stimulation (data not shown). However, the aber-
rant response was observed only when DC was derived
from STAT2m/m (P117) BM with Flt3L but not with GM-
CSF stimulation (data not shown). These results suggest
that STAT2 positively regulates Flt3L- but not GM-CSF -
dependent DC development.Journal of Biomedical Science 2009, 16:22 http://www.jbiomedsci.com/content/16/1/22
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P117 are sensitive to viral infection
It has been previously shown that mice completely lack-
ing STAT2 were extremely susceptible to viral infections
[9]. Since the P117 mice still expressed a trace amount of
functional STAT2, we wondered if the remaining STAT2
could confer antiviral response. First of all, we did antivi-
ral state assay in vitro by pretreating MEFs cells from wild-
type, STAT1KO and P117 mice with 2-fold serial dilution
of IFN starting from 1000 U/ml followed by EMCV
infection at M.O.I. of 0.1 and scored the lytic activity in
MEFs. As shown in Fig. 6A, IFN induced wild-type MEF
antiviral state in a dose-dependent manner. However,
IFN even at 1000 U/ml failed to induce antiviral effect
on either STAT1KO or P117 MEFs.
The impaired antiviral response in vitro was further con-
firmed in vivo. Wild-type and P117 mice were given  0.2 or
200 PFU of EMCV intraperitoneally. As shown in Fig. 6B,
all P117 mice died within 2–4 days after infection with
0.2 pfu of EMCV, while all wild-type mice survived. The
protective effect of STAT2 was obvious as only 1/3 of wild-
type mice succumbed to 200 PFU of EMCV by day 7 (Fig.
6C). The LD50 of EMCV for P117 mice was, at least, 1000-
fold lower than that of wild-type mice. Our work also
showed that P117 mice were susceptible not only to
EMCV but also to VSV infection (data not shown). These
results indicate that P117 mice were extremely susceptible
to viral infections and that the level of functional STAT2
expressed in P117 was not sufficient to protect mice from
infection of different viruses.
Discussion
We reported here the identification and characterization
of the ENU-mutagenized mice p117 that displayed
STAT2 gene rescued IFN response in P117 MEFs Figure 4
STAT2 gene rescued IFN response in P117 MEFs. (A) P117 MEFs were infected with MigR1, MigR1-hSTAT2 or 
MigR1-mSTAT2 recombinant retrovirus. The infection efficiency was indicated by the percentage of GFP positive cells. P117 
MEFs restored with vector alone (v), human STAT2 (hST2) or mouse STAT2 (mST2) gene were left untreated (medium, 
empty bars) or treated with 250 U/ml IFN for 3 h (solid bars) followed by RT-QPCR using primers to OAS (B) or PKR (C). 
Relative mRNA was shown by normalizing the values of OAS or PKR to that of -actin.
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impaired response to type I, but not type II, IFNs. Inherit-
ance test indicates that the deviant phenotype was reces-
sive. Rough genetic mapping suggests that the mutation
accounted for the phenotypes is linked to chromosome
10. Genomic and cDNA sequencing further confirmed a T
to A point mutation located in the 5' splice site of intron
4–5 of STAT2 gene which leads to cryptic splicing and
addition of 5 extra nucleotides between exon 4 and 5,
causing frame shift and generation of stop codons. As a
result, the expression of STAT2 protein was greatly dimin-
ished in the mutant mice. Three lines of evidence suggest
that the mutation in STAT2 is highly likely the cause of the
phenotypes seen in this pedigree. First of all, STAT2 only
participates in type I, but not type II, IFN response. Sec-
ondly, STAT2 gene is located in the chromosome 10
which is in line with the genetic mapping. Thirdly, the res-
toration of human or mouse STAT2 in mutant cells res-
cues IFN response.
Among the seven STAT family members in mice, STAT2 is
relatively special compared to its human counterpart
because of the insertion of a sequence containing 6 tan-
dem copies of a 16 amino acid repeats at its C-terminus
[20,21]. Because this sequence is not present in humans,
it greatly reduces the homology between human and
mouse to less than 40% in TAD domain. It was speculated
Reduced percentage of DCs and impaired Flt3L-dependent DC development in P117 Figure 5
Reduced percentage of DCs and impaired Flt3L-dependent DC development in P117. Splenocytes of STAT2+/m or 
STAT2m/m (P117) mice were stained with antibodies to CD11c, CD86, and B220 or CD11b. The percentage of pDC 
(CD11c+B220+) (A) or cDC (CD11c+CD11b+) (B) in STAT2+/m (upper panels) or STAT2m/m (P117) (lower panels) and the per-
centage of CD86 high gated on these two populations were shown (right panels). (C) The average percentage of cDC and pDC 
of STAT2+/m (empty bars) and STAT2m/m (P117) (solid bars) mice was shown (n = 3). * P < 0.05  BM-derived  pDC and cDC 
from STAT2+/m (empty bars) and STAT2m/m (P117) (solid bars) mice were enumerated and analyzed by flow cytometry and the 
cellularity (D) and the percentage (E) were determined. pDC (F) and cDC (G) of STAT2+/m (upper panels) and STAT2m/m 
(P117) (lower panels) were then stimulated without (left panels) or with LPS plus R848 (right panels) for overnight and stained 
with anti-MHC class II, followed by flow cytometry.
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that these repeats might mediate interactions with species-
specific proteins that are important for the biology of
STAT2. Indeed, Farrar et al. reported that type I IFNs
induce Th1 differentiation in humans but not in mice by
activating STAT4 and recruiting to the IFN receptor com-
plex via the C-terminus of STAT2. The insertion in mouse
STAT2 alters the C-terminus and selectively disrupts its
capacity to activate STAT4 [27]. However, this notion was
negated by the finding that mice expressing a chimeric
mouse STAT2 with human TAD domain were unable to
activate STAT4 and trigger Th1 differentiation [28]. In fact,
overexpression of mouse STAT2 in human U6 cell line
that does not express STAT2 rescues IFN response [21].
Here we also showed that the expression of human STAT2
in mouse P117 MEFs was able to correct the defect (Fig.
4). These data suggest that highly divergent primary
sequences can serve similar functions and that the mini-
mal regions of similarity between human and mouse
STAT2 may define the critical regions for its function.
The roles of type I IFNs in DC development and matura-
tion are still controversial. Hahm et al. reported that mea-
sles virus (MV) or lymphocytic choriomeningitis virus
(LCMV) evades immune system by interfering DC devel-
opment and expansion through generation of type I IFNs
[29]. MV-infected mouse BM cells secrete soluble factors,
including type I IFNs, in vitro to inhibit DC development
from BM of wild-type or STAT1KO but not STAT2KO
mice. Besides, LCMV cl13, which induces systemic type I
IFN production during infection, interferes with DC
expansion in vivo and reduces the frequency of DC pro-
genitor cells within BM of wild-type, STAT1KO but not
Impaired antiviral response in P117 MEFs and mice Figure 6
Impaired antiviral response in P117 MEFs and mice. (A) Wild-type, STAT1KO, and P117 MEFs were pretreated with 2-
fold serial dilution of IFN starting from 1000 U/ml for 24 h, followed by infection with EMCV at a M.O.I of 0.1. Live cells were 
visualized with crystal violet 18 h after the infection. Wild-type (squares) and P117 (triangles) mice were i.p. injected with 0.2 
(B) or 200 (C) pfu/mouse of EMCV and survival rate was recorded every day for 7 days. Numbers in parenthesis represented 
live mice versus total mice at the end of the experiment.
,


596>+?97:$
)>33>,α α α α
*87

	

Days post-infection
 
200 pfu/mouse
$-!
-!
$    % '  	
$
$
%$
$
&$
$$


	
*








"
0.2 pfu/mouse
-!
$-!
$    % '  	
$
$
%$
$
&$
$$
*








"
Days post-infection


	
,
,Journal of Biomedical Science 2009, 16:22 http://www.jbiomedsci.com/content/16/1/22
Page 9 of 11
(page number not for citation purposes)
STAT2KO mice. These results suggest that type I IFNs neg-
atively regulate DC development in a STAT2-dependent
but STAT1-independent manner during viral infection.
However, in IFN receptor knockout mice (IFNARKO),
the expression of costimulatory molecules or MHC class I
and class II in GM-CSF-derived DC was reduced, so was
the proliferating ability of T cells induced by the DCs [30].
Besides, mouse DCs undergo phenotypic maturation
upon exposure to type I IFNs in vitro and in vivo. Recently,
Trinchieri's group reported that the TLR ligand-mediated
induction of CD40 and CD86 was greatly reduced in
splenic pDC and cDC of IFNARKO mice compared to that
of wild-type mice [31]. Since IFN was induced in splenic
DCs upon TLR ligand stimulation, these results also sug-
gest that IFN may participate in a positive feedback reg-
ulation of the maturation of DCs. Here, we showed a
significant reduction of the percentages of splenic pDC
and cDC in STAT2m/m (P117) mice as opposed to STAT2+/
m or wild-type mice. Besides, in vitro assays also showed
that Flt3L-dependent DC development and TLR ligand-
mediated DC differentiation were also defective in cells
from mutant mice (Fig. 5). In fact, gene profiling using
DNA microarray has shown that human BDCA4+ DC or
mouse B220+ plasmacytoid DC are among the highest
expressers of STAT2 mRNA in different tissues and cells,
indicating a physiological requirement of STAT2 for DCs
[32]http://biogps.gnf.org. Taken together, these results
suggest a positively regulatory role of type I IFN and
STAT2 in DC development.
Other than impaired IFN response, P117 mice or cells
were also sensitive to viral infections as indicated by
reduced antiviral state in vitro and increased susceptibility
to EMCV or VSV infection in vivo (Fig. 5 and data not
shown). These phenotypes were very much reminiscent of
STAT1KO or STAT2KO mice [7-9] in which type I IFN
response is also impaired. There are similarities and differ-
ences between STAT2KO and P117 mice. In terms of gene
expression, in general, the macrophages or splenocytes
from both STAT2KO and P117 mice showed impaired
response to type I IFNs while the response to type II IFN
was intact. As for antiviral response, both types of mice are
susceptible to VSV and EMCV infections, judging from
increased viral burdens in STAT2KO mice and increased
lethality in both mice. However, it still remains to be
determined if the susceptibility to viral infection is com-
parable or not between STAT2KO and P117 mice. None-
theless, there are also differences between these two
systems. First of all, a trace amount of functional STAT2 is
still present in P117 mice and it is capable of transducing
signals to induce the expression of downstream OAS gene
and STAT2 itself in response to IFN (Fig. 3C). STAT2 pro-
tein is, however, completely devoid in STAT2KO mice
and, therefore, there is a lack of ISGF3-mediated signaling
in STAT2KO cells in response to IFN. Secondly, basal
level of STAT1 protein is reduced in STAT2KO MEF, which
resulted in a block of type I IFN-dependent induction of
MHC class I and impaired IFN-mediated antiviral
response. We, however, did not observe any reduction of
STAT1 protein in P117 MEF (data not shown) although
the response to IFN has yet to be determined. The differ-
ential expression of basal level of STAT1 protein in these
MEFs may lie in the presence of the residual STAT2 pro-
tein in P117 MEF, which may trigger a type I IFN-depend-
ent autocrine loop to maintain the basal level of STAT1
expression in P117 cells [9,33-35]. Nonetheless, suscepti-
bility of the mutant mice to viral infections also indicates
that the residual STAT2 is not sufficient to mount an anti-
viral response and there is a threshold requirement of
STAT2 for type I IFNs to be fully functional.
Materials and methods
Mice and cells
ENU-mutagenized mice were generated in the Mouse
Mutagenesis Program Core Facility (MMPCF) at the
Academia Sinica, Taiwan. The generation of ENU mice
was done as described [36]. P117 mice were bred in
C57BL/6J background. In this study, we use 6~8 week-old
STAT2m/m  (P117), STAT2+/m, and wild-type littermate
mice to do experiments. All mice are housed in the SPF
environment at the NTUMC Animal Core Facility and the
protocol was approved by the Institutional Animal Care
and Use Committee at NTU. Generation of P117 embry-
onic fibroblasts (MEF) was done as described in the Cur-
rent Protocols in Molecular Biology Unit 28.1. Primary
MEFs were spontaneously immortalized by passaging the
cells till they passed crisis. wild-type and STAT1KO MEF
cell lines were provided by Dr. David Levy at New York
University Medical Center Department of Pathology.
Interval haplotype analysis
The interval haplotype analysis was done as described
[19]. Briefly, genotype of a proximal and a distal marker
for 21 chromosomal intervals distributed across the
mouse genome (corresponding to two intervals for Chro-
mosomes 1 and 2 and one for the remaining 17 auto-
somes) were used to do haplotyping. Male mice of P117
(C57BL/6 genetic background) were mated with C3H/HeJ
females to generated F1 offspring that were then inter-
crossed to generate F2 mice. DNA samples obtained from
15 individual affected F2 mice were then subjected to
interval haplotype analysis.
Flow cytometry
Cells stimulated without or with IFNs were stained with
fluorescence conjugated antibodies and subjected to flow
cytometry analysis using FCASCanto (BD Biosciences).
Antibodies used were the follows CD11b-FITC, CD11c-
APC, B220-PE/FITC, CD86-PE/FITC, MHC I-FITC and
ICAM-1-APC (all from e-bioscience). Stimulation indexJournal of Biomedical Science 2009, 16:22 http://www.jbiomedsci.com/content/16/1/22
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was calculated as follows (% MHC Ihigh or ICAM-1high after
treatment - % MHC I high or ICAM-1high before treatment)/
% MHC I high or ICAM-1high before treatment.
Real-time RT-QPCR
mRNA of PBL before and after IFN treatment was pre-
pared using TurboCapture 96 mRNA kit (Qiagen) accord-
ing to manufacturer's instructions. In some experiments,
TRIzol reagent (Invitrogen) was used to prepare total RNA
of splenocytes. One to three g total RNAs prepared from
cells treated with 250 U/ml IFN (Merck) or 50 ng/ml
IFN (Peprotech) for indicated times were subjected to
reverse transcription. Quantitative real-time PCRs were
carried out on the iCycler iQ real-time detection system
(Bio-Rad). Each sample was performed in duplicates. The
primer sequences used for PCR are the follows.
-actin Forward 5'-AGGGAAATCGTGCGTGAC-3'
Reverse 5'-GCTCGTTGCCAATAGTGATG-3'
IP-10 Forward 5'-TGAGCAGAGATGTCTGAATCCG-3'
Reverse 5'-TGTCCATCCATCGCAGCA-3'
OAS Forward 5'-GCCATTGCACGCTCGCCTACTAC-3'
Reverse 5'-CTCCTGCCATCCGGGTTTTTCA-3'
PKR Forward 5'-TGCGCAGACAATGTATGGTAC-3'
Reverse 5'-ATGTGACAACGCTAGAGGATG-3'
SOCS1 Forward 5'-CCTGGTTGTAGCAGCTTGT-3'
Reverse 5'-CGACCCCTGGTTTGTGCAA-3'
Western blotting
Total cell lysates of splenocytes or MEFs that were treated
without or with IFN (IFN 50 ng/ml or IFN 250 U/ml)
for indicated times were subjected to electrophoresis.
After transferring to nitrocellulose membrane, antibodies
to tubulin (Sigma), phospho-STAT1 (tyrosine 701,
Zymed), phospho-STAT2 (tyrosine 689, Upstate), and
home-made rabbit antibodies to STATI and STAT2 were
used for blotting.
Retroviral transduction
Transduction of retroviruses into MEFs were done as
described [37]. Briefly, a bicistronic retroviral vector con-
taining mouse or human STAT2 cDNA and GFP was co-
transfected with a plasmid expressing VSV G into 293T
cells for 2 days before collecting the virus supernatant.
MEFs were incubated with the virus supernatant in the
presence of 8 g/ml polybrene and spun at 1100 g for 90
min at 30°C. Flow cytometry were performed to measure
GFP expression as an indicator of transduction efficiency
in MEFs 2 days after the infection.
In vitro culture of DCs
In vitro culture of DCs was done as described previously
with slight modification [38]. Briefly, 1 × 107 BM cells
were cultured in 10 ml of 10% FBS containing RPMI-1640
supplemented with 100 ng/ml mouse Flt3L (Peprotech),
50 M -ME (Sigma) and 50 g/ml Gentamicin (Invitro-
gen) for 8 days. Different subsets of DCs were identified
by staining the cells with anti-CD11c-APC, anti-CD11b-
FITC and anti-B220-PE antibodies followed by flow
cytometry. pDC (CD11c+CD11b-B220+) and cDC
(CD11c+CD11b+B220-) were then sorted using FACSAria
(BD Biosciences) and rested for 1 day before being stimu-
lated with LPS 0.1 g/ml plus R848 1 g/ml for overnight
and measured the expression of MHC class II using anti-I-
A/I-E-PE antibody (Biolegend) to stain cells and measured
by flow cytometry.
In vitro and in vivo antiviral assays
For in vitro assay, wild-type, STAT1KO, or P117 MEFs were
pretreated with 2-fold serial dilution of IFN (1000 U/ml
to 0.98 U/ml) for 24 h. EMCV at a M.O.I of 0.1 was added
in serum free DMEM medium for 45 min 37°C. Viral
supernatant was removed and the cells were refreshed
with complete medium. Eighteen hours post-infection,
medium was removed and cells were fixed with 10% for-
maldehyde solution for 20 min at RT. After fixation, cells
were visualized with crystal violet. The excessive dye was
then removed by immersing the plate in water. For in vivo
assay, wild-type and P117 mice were infected with 0.2 or
200 pfu/mouse of EMCV by intraperitoneal injection. The
survival rate was recorded every 24 h for 7 days.
Statistics
Student's T test (two-tailed) was used for statistical analy-
sis.
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